Tilray | TRLY - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Acasti Pharma USD 1000 261.04M 2024-12
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.38M 172K 2026-03
Aurora Cannabis CAD 58.95M 2.24M 2026-03
Canopy Growth CAD 422.07M 53.78M 2026-03
Cronos Group USD 376.26M 5.33M 2026-03
Dianthus Therapeutics USD 54.58M 11.36M 2026-03
Divis Laboratories Ltd INR 265.47M 0 2026-03
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Moderna USD 391M 2M 2025-09
Organigram Holdings CAD 136.47M 1.34M 2026-03
Organon & Co USD 262.65M 2.33M 2026-03
Revvity USD 111.8M 1.57M 2026-03
Tectonic Therapeutic USD 18.83M 92.19K 2026-03
Tilray USD 116.52M 5.01M 2025-09
Viatris USD 1.16B 5.27M 2026-03
Xeris Pharmaceuticals USD 172.56M 6.34M 2026-03
Zealand Pharma A/S 70.61M 319.68K 2025-12